Age-dependent alterations in the tumoricidal functions of tumor- associated macrophages

Tumor Biology

Volumn 20, Issue 1, 1999, Pages 30-43

  Khare, Vineeta ^a   Sodhi, Ajit ^a   Singh, Sukh Mahendra ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Aging; Dalton's lymphoma; Tumor cytotoxicity; Tumor associated macrophages

Indexed keywords

CALCIUM ION; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NITRIC OXIDE SYNTHASE; NITROGEN; ONCOSTATIN M;

ADOLESCENT; AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CANCER STAGING; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; MALE; MELANOMA CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; REPRODUCTION; T CELL LYMPHOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

EID: 0032960741     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056519     Document Type: Article

References (34)

1. Keller R, Geiges M, Keisth R: L-Arginine-dependent reactive nitrogen intermediates as mediator of tumor cell killing by activated macrophages. Cancer Res 1990;15:421-425.
2. Chen Y, Bradley SF: Aging and elciting agents: Effect on murine macrophage monokine bioactivity. Exp Gerontol 1993;28:145-159.
3. Nathan CF: Secretory products of macrophages. J Clin Invest 1987;19: 319-326.
4. Jiang H, Stewart CA, Leu RW: Tumor derived soluble factors synergize with interferon-gamma and LPS, IL-2 or TNF receptors for autocrine induction of NOS and enhance NO mediated tumor cytoxicity. Immunobiology 1995;192:321-342.
5. Dinarello CA: The biological properties of interleukin-1. Eur Cytokine Netw 1994;5:517-531.
6. Bruce AG, Linsley PS, Rose TM: Oncostatin-M. Prog Growth Factor Res 1992;4:157-170.
7. Sodhi A, Shishodia S, Srivastava A: Cisplatin stimulated bone-marrow derived macrophages secrete oncostatin-M. Immunol Cell Biol 1997; 75:492-496.
8. Wustro TPU, Denny TN, Fernandes G, Good RA: Changes in macrophages and their functions with aging in C57BL/6J, AKR/J and SJL/J mice. Cell Immunol 1982;46: 801-808.
9. Vetricka V, Tlaskalova-Hogenova H, Pospisil M: Impaired antigen presenting function of macrophages from aged mice. Immunol Invest 1985;14:105-109.
10. Tateda K, Matsumoto T, Miyazaki S, Yamaguchi K: Lipopolysaccharide-induced lethality and cytokine production in aged mice. Infect Immun 1996;64:769-774.
11. Khare V, Sodhi A, Singh SM: Effect of aging on the tumoricidal functions of murine peritoneal macrophages. Nat Immunity 1996-97;15: 285-294.
12. Ding A, Hwang S, Schwab R: Effect of aging on murine macrophage. Diminished response to IFN-γ for enhanced oxidative metabolism. J Immunol 1994;153:2146-2152.
13. 2. J Immunol 1994;153:1674-1685.
14. Kumar A, Singh SM: Effects of cisplatin on the proliferation and differentiation of bone marrow cells of tumor-bearing mice. Immunol Cell Biol 1995;73:220-225.
15. Parajuli P, Singh SM, Kumar A: Effect of cisplatin and FK565 on the activation of tumor-associated and bone marrow-derived macrophages by Dalton's lymphoma. Int J Immunopharmacol 1995;17:1-7.
16. Parajuli P, Singh SM, Kumar A, Sodhi A: Alterations in the tumoricidal functions of murine tumor-associated macrophages during progressive growth of a tumor in vivo. Cancer J 1997;10:222-228.
17. Udaychander M, Meenakshi A, Muthiah R: Tumor targeting potential of liposomes encapsulating Ga-67 and antibody to Dalton's Lymphoma-associated antigen (Anti-DLAA). Int J Radiat Oncol Biol Phys 1987;13:1713-1719.
18. Singh SM, Sodhi A: Interaction between cisplatin-treated macrophages with Dalton's lymphoma cells in vitro. Exp Cell Biol 1988;56: 1-11.
19. McLachlan JA, Serkin CD, Morrey KM, Bakouche O: Antitumoral properties of aged human monocytes. J Immunol 1995;154:832-843.
20. Sodhi A, Singh SM: Release of cytolytic factor(s) by murine macrophages in vitro on treatment with cisplatin. Int J Immunopharmacol 1986;8:701-707.
21. Kimball PM, Gamaz N, Sell S: Two episodes of calcium uptake associated with T-lymphocyte activation. Cell Immunol 1988;113:107-116.
22. Ding AH, Nathan CF, Stuehr DJ: Release of reactive nitrogen intermediates and reactive oxygen intermediates from murine peritoneal macrophages. J Immunol 1988;141: 2407-2412.
23. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GL: Oncostatin M: A growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci USA 1986;83:9739-9743.
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-254.
25. Adams DO, Hamilton TA: The cell biology of macrophage activation. Annu Rev Immunol 1984;2:283-318.
26. Dinapoli MR, Calderon CL, Lopez DM: The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J Exp Med 1996;183:1323-1329.
27. Chen Y, Johnson AG: In vivo activation of macrophages by prolactin from young and aging mice. Int J Immunopharmacol 1988;15:39-45.
28. 2. J Immunol 1995;154: 1909-1918.
29. Travis J: Do tumor altered T cells depress immune responses. Science 1992;258:1732-1740.
30. Fidler IJ, Klienerman ES: Therapy of cancer metastasis by systemic activation of macrophages. Res Immunol 1993;144:284-287.
31. Kambayashi I, Alexander HR, Fong M: Potential involvement of IL-10 in suppressing tumor-associated macrophages. J Immunol 1995;154: 3383-3390.
32. Tsunawaki S, Sporn S, Nathan C: Comparison of transforming growth factor-β and a macrophage deactivating polypeptide from tumor cells. J Immunol 1989;142:3462-3467.
33. Tsuchya Y, Igarashi M, Suzuki R: Production of colony-stimulating factor by tumor cells and the factor mediated induction of suppressor cells. J Immunol 1988;141:699-708.
34. Kumar A, Parajuli P, Singh SM: Gangliosides produced by T cell lymphoma inhibit the production of reactive nitrogen intermediates by murine peritoneal macrophages. J Clin Biochem Nutr 1996;21:171-182.